NIH-funded research R01 grant

Gut microbes and blood markers linked to heart and blood vessel problems in people with HIV

Official title: Multi-omic signatures of gut dysbiosis and cardiovascular comorbidities associated with HIV infection

Funded at Albert Einstein College of Medicine · NIH-11089534 · Data updated 2026-11-12

This project looks for patterns in gut microbes and blood-based markers that relate to heart and blood vessel problems in people living with HIV.

More HIV Infection research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionAlbert Einstein College of Medicine
NIH-funded
Lab location1 site (Bronx, United States)
Project startSeptember 1, 2023
Project endMay 31, 2027
Funding year2025
Award (this year)$705,769
NIH project number5R01HL170904-03
Project IDNIH-11089534 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are adults enrolled in the MWCCS (formerly WIHS and MACS), especially people living with HIV who can provide stool and blood samples and undergo carotid ultrasound and echocardiography.

Less likely to help

People not enrolled at a participating MWCCS site, unwilling to provide biological samples or undergo imaging, or those without relevant cardiovascular risk factors may not be eligible and are unlikely to receive direct benefit.

What this research studies

If you join, researchers will analyze stool and blood from up to 2,000 participants (about 65% living with HIV) enrolled in the MWCCS to look for microbial and molecular patterns. They will use metagenomics, transcriptomics, and proteomics to measure gut bacteria, host immune signals, and metabolites and link these data to carotid ultrasound and heart echocardiogram results. Heart and vessel measures include carotid plaque, arterial stiffness, and several measures of left ventricular function and strain. The team aims to find shared biological signatures that help explain higher rates of atherosclerosis and heart dysfunction in people with HIV.

Why it matters

Potential benefit: If successful, this work could identify biomarkers that help detect or prevent heart and blood vessel disease in people living with HIV.

How similar studies have gone: Earlier analyses in the WIHS cohort have linked specific gut bacteria and immune/metabolic markers to carotid atherosclerosis, but applying broad multi-omics across a larger, mixed-sex cohort and multiple cardiac measures is a newer and less-tested approach.

Where this research is happening

  • Albert Einstein College of Medicine
    Bronx, United States
    Active

Researchers

  • Principal investigator: Qi, Qibin — Albert Einstein College of Medicine
  • Study coordinator: Qi, Qibin

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.